Your browser doesn't support javascript.
loading
RIPK3 as a potential therapeutic target for Gaucher's disease.
Vitner, Einat B; Salomon, Ran; Farfel-Becker, Tamar; Meshcheriakova, Anna; Ali, Mohammad; Klein, Andrés D; Platt, Frances M; Cox, Timothy M; Futerman, Anthony H.
Afiliação
  • Vitner EB; 1] Department of Biological Chemistry, Weizmann Institute of Science, Rehovot, Israel. [2].
  • Salomon R; 1] Department of Biological Chemistry, Weizmann Institute of Science, Rehovot, Israel. [2].
  • Farfel-Becker T; Department of Biological Chemistry, Weizmann Institute of Science, Rehovot, Israel.
  • Meshcheriakova A; Department of Biological Chemistry, Weizmann Institute of Science, Rehovot, Israel.
  • Ali M; Department of Biological Chemistry, Weizmann Institute of Science, Rehovot, Israel.
  • Klein AD; Department of Biological Chemistry, Weizmann Institute of Science, Rehovot, Israel.
  • Platt FM; Department of Pharmacology, University of Oxford, Oxford, UK.
  • Cox TM; Department of Medicine, University of Cambridge, Cambridge, UK.
  • Futerman AH; Department of Biological Chemistry, Weizmann Institute of Science, Rehovot, Israel.
Nat Med ; 20(2): 204-8, 2014 Feb.
Article em En | MEDLINE | ID: mdl-24441827
Assuntos
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Encéfalo / Morte Celular / Proteína Serina-Treonina Quinases de Interação com Receptores / Doença de Gaucher Idioma: En Ano de publicação: 2014 Tipo de documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Encéfalo / Morte Celular / Proteína Serina-Treonina Quinases de Interação com Receptores / Doença de Gaucher Idioma: En Ano de publicação: 2014 Tipo de documento: Article